Sort
15,440 grants matching “organoids”
Leader cell development and function in Breast Tumor Collective Migration
$474,135Gregory Longmore · Washington University · R01 · FY2024 · CA
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
$474,114Roberta M O'Connor · Washington State University · R01 · FY2020 · AI
DEVELOPMENTAL FUNDS (Core-002)
$474,044Beverly Shriver Mitchell · Stanford University · P30 · FY2018 · CA
DEVELOPMENTAL FUNDS (Core-002)
$474,044Beverly Shriver Mitchell · Stanford University · P30 · FY2020 · CA
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
$474,007Craig Lewis Duvall · Vanderbilt University · R01 · FY2020 · EB
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$473,937Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
$473,881Josep M Llovet · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Molecular mechanisms of prostate cancer metastasis
$473,852Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA
Molecular mechanisms of prostate cancer metastasis
$473,850Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2021 · CA
Intestinal O-GlcNAc signaling and mucosal host defense
$473,750Hai-Bin Ruan · University Of Minnesota · R01 · FY2025 · AI
Molecular Characterization of Pontocerebellar Hypoplasia
$473,741Joseph G Gleeson · University Of California, San Diego · R01 · FY2023 · NS
Molecular Characterization of Pontocerebellar Hypoplasia
$473,741Joseph G Gleeson · University Of California, San Diego · R01 · FY2025 · NS
Molecular Characterization of Pontocerebellar Hypoplasia
$473,741Joseph G Gleeson · University Of California, San Diego · R01 · FY2022 · NS
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$473,623Ankur Singh · Georgia Institute Of Technology · R01 · FY2021 · CA
Organoid models of KRAS mutant cancer
$473,481Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
$473,358Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Establishing the Repertoire of Actionable Alterations in Appendiceal Adenocarcinoma
$473,282Lance David Miller · Wake Forest University Health Sciences · R01 · FY2024 · CA
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
$473,270Ethan Vincent Abel · Roswell Park Cancer Institute Corp · R37 · FY2023 · CA
Mitigation of GI-ARS by Lactobacillus species
$473,168Radhakrishna Rao · University Of Tennessee Health Sci Ctr · U01 · FY2025 · AI
Control of Seizure and Migraine Susceptibility by GPR37L1
$473,153Randy A. Hall · Emory University · R01 · FY2024 · NS
Custom-engineering a 3D brain organoid platform to model viral infections of the central nervous system
$473,126Guo-Li Ming · University Of Pennsylvania · U19 · FY2018 · AI
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$473,003Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
TBEL Project 2
$472,982Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Coordination of stress-adaptive cell states by CRIPTO in breast cancer heterogeneity and progression
$472,921Benjamin T Spike · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Sex steroid signaling and adaptive growth of the intestine
$472,704Bruce A Edgar · University Of Utah · R01 · FY2022 · DK